Invivyd (IVVD) Change in Inventory (2024 - 2025)
Invivyd posted quarterly Change in Inventory of $352000.0 for Q4 2025, down 76.5% year-on-year from $1.5 million in Q4 2024, and up 804.0% on a QoQ basis from -$50000.0 in Q3 2025.
Invivyd (IVVD) has 2 years of Change in Inventory data on file, last reported at $352000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory fell 76.5% year-over-year to $352000.0; the trailing twelve-month figure through Dec 2025 stood at $373000.0 (down 98.5% YoY), and the FY2025 full-year result was $373000.0, down 98.5% from the prior year.
- Change in Inventory for Q4 2025 stood at $352000.0, up from -$50000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $20.8 million in Q3 2024 and bottomed at -$50000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 352,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 20.76 Mn |
| Sep 30, 2024 | 20.76 Mn |
| Jun 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 2.53 Mn |
| Mar 31, 2024 | 104,000.00 |
| Mar 31, 2024 | 104,000.00 |